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For patients with sickle cell disease (SCD) who lack access to specialists 
or primary care physicians informed about their condition, health care is 
often limited to the emergency department (ED). New data from the Sickle 
Cell Data Collection programs in California and Georgia shows that public 
payers are responsible for the majority of costs associated with these ED 
visits. An increased focus on access to high-quality, coordinated care — 
both preventive and SCD-related — may decrease ED visits and costs, 
while improving quality of life for this population.
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ED Use is Common for sickle cell patients
In 2016, there were a total of 33,630 
SCD-related visits to EDs in California 
and Georgia, including a marked 
increase in ED visits among patients in 
early adulthood, as they transition from 
pediatric to adult care. ED visits for those 
aged 20 to 39 years accounted for more 
than half of all ED visits by SCD patients.  
While some negative effects of the 
disease are more likely as patients age 
(e.g., organ damage and stroke-related 
disability), this increase in ED visits may 
also be related to the lack of insurance 
and access to comprehensive care that 
adults with SCD commonly experience.
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Percentage of All SCD-Related ED Visits  
In California and Georgia by Age Group, 2016
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Previous studies have shown that medical expenditures for patients with SCD are considerably higher than 
similarly insured and similarly aged patients without SCD.1 Lifetime medical costs for patients with SCD are 
substantial — $1 million for an SCD patient reaching 45 years of age.1 Given the high-cost of care, payers are 
incentivized to find cost-effective means to reduce costly ED visits due to disease crises.
Policy Implications 
It has been shown for other chronic conditions that having a regular doctor and coordinated care — which 
might include case management, home visits, or telemedicine consultations — can reduce ED visits and cut 
total medical costs.2-4 If the same holds for patients with SCD, these findings suggest a potential for significant 
savings. Better access to SCD-specific outpatient care that follows evidence-based practice recommendations 
may improve overall disease management of SCD and decrease reliance on expensive ED services.5 
Policymakers may find these data from the Sickle Cell Data Collection programs helpful as they consider ways 
to improve SCD patients’ access to outpatient care, to develop coordinated care models for patients with 
SCD, and to increase SCD expertise among health care providers (through education, workforce incentives, 
and telemedicine).
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Public Payers Fund Majority of SCD-Related Emergency Visits
Over the three-year period from 2014 to 2016, data from the Sickle Cell Data Collection programs shows that 
in both California and Georgia, public payers — Medicare and Medicaid — paid for more than 70% of SCD-
related ED costs. 
